Lisa DeTora

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

Lisa DeTora, Dikran Toroser, Angela Sykes et al. · Annals of Internal Medicine · 2022 · 243 citations

Preclinical Therapeutics, Biomedical Ethic, Clinical Guidelines +17

Characterization of Etoricoxib, a Novel, Selective COX‐2 Inhibitor

Aimée Dallob, Christopher J. Hawkey, Howard Greenberg et al. · The Journal of Clinical Pharmacology · 2003 · 91 citations

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis

K. E. Truitt, Rhoda Sperling, W. H. Ettinger et al. · Aging Clinical and Experimental Research · 2001 · 79 citations

Advanced Elderly Patients, Chronic Musculoskeletal Condition, Clinical Trials +4

Interlaboratory Standardization of the Sandwich Enzyme-Linked Immunosorbent Assay Designed for MATS, a Rapid, Reproducible Method for Estimating the Strain Coverage of Investigational Vaccines

Brian D. Plikaytis, Maria Stella, Giuseppe Boccadifuoco et al. · Clinical and Vaccine Immunology · 2012 · 63 citations · Full text

Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source

Christopher Gill, Sanjay Ram, Jo Anne Welsch et al. · Vaccine · 2011 · 52 citations

Complement Source, Serum Bactericidal Activity, Medical Microbiology +9